Samuel Eric Greenberg

Title: Samuel Eric Greenberg: Innovator in Liposomal Formulations

Introduction

Samuel Eric Greenberg is a notable inventor based in Los Gatos, California. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work on liposomal therapies. His research focuses on the development of phosphorylated carbohydrate replacement therapies, which have the potential to address various metabolic disorders.

Latest Patents

Samuel Eric Greenberg holds a patent for "Liposomal formulations, and methods of using and preparing thereof." This patent provides a detailed disclosure of phosphorylated carbohydrate replacement therapies that include compositions of phosphorylated carbohydrates and phospholipids. The methods outlined in the patent are designed for the pharmaceutical delivery of these carbohydrates to the cell interior, endoplasmic reticulum, and Golgi apparatus. This innovation is particularly relevant for treating CDG type I and CDG type II diseases, as well as other metabolic disorders.

Career Highlights

Greenberg's career is marked by his dedication to advancing medical science through innovative formulations. His work at Glycomine, Inc. has positioned him as a key player in the development of therapies that can significantly improve patient outcomes. His expertise in liposomal formulations has garnered attention in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Agnes Rafalko and Teppei Shirakura. Their collaborative efforts contribute to the ongoing research and development of effective therapies in the field.

Conclusion

Samuel Eric Greenberg's contributions to liposomal formulations and his innovative approach to addressing metabolic disorders highlight his importance in the field of pharmaceutical science. His work continues to pave the way for new therapeutic options that can improve the quality of life for patients suffering from complex diseases.